sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> influenza vaccine market

report

Influenza Vaccine Market, by Type (Seasonal Influenza, Pandemic Influenza, Zoonotic Influenza), Technology (Virus-Like Particles Influenza Vaccine, Vectored Influenza Vaccine, Cell-Based Produced LAIV), End-User (Research Centers, Hospitals, Clinics) – Global Revenue, Trends, Growth, Share, Size, and Forecast To 2022

HC276 March 2017 100+ FREE 10% CUSTOMIZATION

Influenza causes catarrh, fever, and severe aching and also occurs in epidemics. It is a common infection and every year millions suffer from this viral infection. It mostly impacts elderly and child populations. North America and Europe are the top consumers of influenza vaccines because of rise of geriatric population and increase in the government support for new vaccination technologies. Asia-Pacific is supposed to have a high growth rate in future for the influenza vaccine market because of large population, rapidly improving healthcare system in the region, and increase in the investment on R&D activities.

The report on the global influenza vaccine market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The key reasons for the growth of influenza vaccine market are technological advancements in the field of healthcare, rising geriatric population, and increase in the number of new vaccine launches.
  • The growing awareness among people about influenza in developing countries is one of the key growth opportunities in the influenza vaccine market.
  • However, the influenza vaccine market will be hampered by the lack of properly trained professionals and vaccine facilities.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s influenza vaccine market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the influenza vaccine market by the following segments:

  • Influenza Vaccine Market, by Type
    • Seasonal Influenza
    • Pandemic Influenza
    • Zoonotic Influenza
  • Influenza Vaccine Market, by Technology
    • Virus-Like Particles Influenza Vaccine
    • Vectored Influenza Vaccine
    • Cell-Based Produced LAIV
  • Influenza Vaccine Market, by End-User
    • Research Centers
    • Hospitals
    • Clinics

KEY MARKET PLAYERS

Key players in the influenza vaccine market include:

  • Abbott Laboratories
  • Astrazeneca PLC
  • Biocryst Pharmaceuticals, Inc.
  • CSL Limited
  • Daiichi Sankyo Co., Ltd.
  • Glaxosmithkline PLC
  • Hualan Biological Engineering Inc.
  • Instituto Butantan
  • Mitsubishi Tanabe Pharma Corporation

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • MIDDLE EAST & AFRICA
    • GCC
    • North Africa
    • South Africa
    • Rest of Middle East & Africa
  • LATIN AMERICA
    • Brazil
    • Rest of Latin America

TRENDING RELATED REPORT

Orphan Drugs Market, by Type (Biological Orphan Drugs, Non-Biological Orphan Drugs), Therapeutic Area (Oncology, Neurology, Hematology, Infectious Disease, Metabolic Disease, and Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Product Roadmap
  5. INFLUENZA VACCINE MARKET, BY TYPE
    1. Segment Share
    2. Type
      1. Seasonal Influenza
      2. Pandemic Influenza
      3. Zoonotic Influenza
  6. INFLUENZA VACCINE MARKET, BY TECHNOLOGY
    1. Segment Share
    2. Technology
      1. Virus-Like Particles Influenza Vaccine
      2. Vectored Influenza Vaccine
      3. Cell-Based Produced LAIV
  7. INFLUENZA VACCINE MARKET, BY END-USER
    1. Segment Share
    2. End-user
      1. Research Centers
      2. Hospitals
      3. Clinics
  8. INFLUENZA VACCINE MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Type
      3. By Technology
      4. By End-user
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K
        4. Rest of Europe
      2. By Type
      3. By Technology
      4. By End-user
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Type
      3. By Technology
      4. By End-user
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Type
      3. By Technology
      4. By End-user
  9. COMPETITIVE LANDSCAPE
    1. Market Share Analysis, 2015 (%)
    2. Key Innovators
  10. KEY MARKET PLAYERS
    1. Abbott Laboratories
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Astrazeneca PLC
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Biocryst Pharmaceuticals, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. CSL Limited
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Daiichi Sankyo Co., Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Glaxosmithkline PLC
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Hualan Biological Engineering Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Instituto Butantan
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Mitsubishi Tanabe Pharma Corporation
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us